Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.

Autor:	Jöris, M M1, Bierings, M B2, Egeler, R M3, Claas, F H J4, van Rood, J J1, Oudshoorn, M1
Zdroj:	Bone Marrow Transplantation. May2012, Vol. 47 Issue 5, p677-683. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu